- Home
- RDHL vs GCTK Comparison
RDHL vs GCTK Comparison
Compare RDHL & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- GCTK
- Stock Information
- Founded
- RDHL 2009
- GCTK 2001
- Country
- RDHL Israel
- GCTK United States
- Employees
- RDHL N/A
- GCTK N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- GCTK Medical/Dental Instruments
- Sector
- RDHL Health Care
- GCTK Health Care
- Exchange
- RDHL Nasdaq
- GCTK Nasdaq
- Market Cap
- RDHL 3.9M
- GCTK 3.3M
- IPO Year
- RDHL N/A
- GCTK N/A
- Fundamental
- Price
- RDHL $1.51
- GCTK $10.59
- Analyst Decision
- RDHL
- GCTK
- Analyst Count
- RDHL 0
- GCTK 0
- Target Price
- RDHL N/A
- GCTK N/A
- AVG Volume (30 Days)
- RDHL 88.5K
- GCTK 4.0M
- Earning Date
- RDHL 09-05-2025
- GCTK 08-14-2025
- Dividend Yield
- RDHL N/A
- GCTK N/A
- EPS Growth
- RDHL N/A
- GCTK N/A
- EPS
- RDHL N/A
- GCTK N/A
- Revenue
- RDHL $9,550,000.00
- GCTK N/A
- Revenue This Year
- RDHL $381.91
- GCTK N/A
- Revenue Next Year
- RDHL N/A
- GCTK N/A
- P/E Ratio
- RDHL N/A
- GCTK N/A
- Revenue Growth
- RDHL 157.62
- GCTK N/A
- 52 Week Low
- RDHL $1.06
- GCTK $4.22
- 52 Week High
- RDHL $11.70
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- RDHL 54.23
- GCTK 79.88
- Support Level
- RDHL $1.22
- GCTK $4.33
- Resistance Level
- RDHL $1.60
- GCTK $5.88
- Average True Range (ATR)
- RDHL 0.08
- GCTK 0.88
- MACD
- RDHL 0.04
- GCTK 0.42
- Stochastic Oscillator
- RDHL 76.32
- GCTK 64.21
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.